Showing 131-140 of 440 results for "".
MATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus VelocityMATV News: New FDA Approved Cellulite Treatment; Global Alliance Takes on Patient Safety, Medical Tourism
https://modernaesthetics.com/series/matv-news/matv-news-new-fda-approved-cellulite-treatment-global-alliance-takes-on-patient-safety-medical-tourism/33354/The International Society of Aesthetic Plastic Surgery forms a new Global Alliance to advise and consult on all concerns relating to cosmetic surgery, including medical tourism. Could breast implant size selection systems based on breast tissue measurements provide better outcomes? Also, Syneron CanMATV News: Phat Lips, #BreaktheIce, Pathway to Purchase
https://modernaesthetics.com/series/matv-news/matv-news-phat-lips-breaktheice-pathway-to-purchase/33410/This edition of MATV News, from the editors of Modern Aesthetics® magazine, covers new data from CareCredit's Pathway to Purchase study and the American Society of Plastic Surgeons shows lip envy (think Jennifer Lawrence) is driving demand for treatment. Also, Galderma launches the "Don't Freeze Me,MATV News: New ASAPS Stats; AAD Annual Meeting Coverage
https://modernaesthetics.com/series/matv-news/matv-news-new-asaps-stats-aad-annual-meeting-coverage/33413/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we cover new statistics from the American Society for Aesthetic Plastic Surgery and aesthetic news from the American Academy of Dermatology's 74th Annual Meeting. Also in this episode, new applicators are available for CoMATV News: Long-Term Efficacy Results for Bellafill; Clear + Brilliant Pélo Cleared for Hair Removal
https://modernaesthetics.com/series/matv-news/matv-news-long-term-efficacy-results-for-bellafill-clear-brilliant-pelo-cleared-for-hair-removal/33416/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the five-year efficacy results for Suneva's Bellafill and why needle size matters for neurotoxin injections. Also in this edition, FDA approves Solta's Clear + Brilliant Pélo for hair removal, AAFPRS Annual MeetLaunching Your Private Practice: Key Steps for Success
https://modernaesthetics.com/ma-issues-index/2025-may-june/launching-your-private-practice-key-steps-for-success/36075/An engaging session with Dr. Michael SomenekLooking to the Sea: Kelp-Based Formula Shows Anti-Aging Effects and More
https://modernaesthetics.com/ma-issues-index/2023-nov-dec/looking-to-the-sea-kelp-based-formula-shows-anti-aging-effects-and-more-1/35331/A fermented kelp-based product showed anti-inflammatory and anti-aging results in some studies.Evolving Perspectives: The Aesthetics Mergers & Acquisitions Market Today
https://modernaesthetics.com/ma-issues-index/2023-july-aug/evolving-perspectives-the-aesthetics-mergers-acquisitions-market-today/35301/A survey of some of the most seasoned buyers and experts in the industry gathers their sentiments on the industry, mergers and acquisitions (M&A) activity, and the state of the economy today.Ozempic: Implications for Aesthetic Medicine
https://modernaesthetics.com/ma-issues-index/2023-mar-apr/ozempic-implications-for-aesthetic-medicine/35260/Fat loss is fat loss, and our experts have the solutions—as well as some questions of their own.The Science of Regenerative Medicine and Exosomes
https://modernaesthetics.com/ma-issues-index/2022-july-aug/the-science-of-regenerative-medicine-and-exosomes/35186/Exosomes hold promise for medical and aesthetic applications, but there is much to learn about sourcing and optimal application.